#ASH20 was fully virtual due to the pandemic. #ASH21 will be a hybrid of virtual and in-person meetings by choice. At least that is my hope and prediction. The virtual format allowed us to log from the comfort of our home and we were at the mercy of the WIFI and not an overflowing meeting […]
There is no doubt that patients who continue maintenance Revlimid (lenalidomide) following autologous transplant do better than those who do not. Dr. Phil McCarthy showed unequivocally in CALGB 100104 (Revlimid vs placebo) that progression free survival (PFS) and overall survival (OS) are longer for patients taking maintenance Revlimid. Likewise, maintenance therapy extends PFS for patients […]
